Track the Shanghai Bio-heart Biological Technology Co., Ltd. - B share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Shanghai Bio-heart Biological Technology Co., Ltd. - B has recorded 21 public disclosures. Market capitalisation: €555m. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: Wang Philip Li. Every trade is free.
21
Insider Decl.
n/a
Thresholds
€99,815
21 ops.
Buy Volume
n/a
n/a
Sell Volume
14Σ signal
Buys €99,815n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,895 of 28,892 companies
25.7
score / 100
Value
13
Quality
38
FCF yld-14%
Earn yld-13%
EV/EBITDA·
ROE-11%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ HK$4.260.0051% mcap4.6% of flowShareXHKGHKEX:DA20260416E00579
21 of 21 declarations
About Shanghai Bio-heart Biological Technology Co., Ltd. - B
Shanghai Bio-heart Biological Technology Co., Ltd. is a company focused on developing biological technologies for the healthcare sector. It is listed on the Hong Kong Stock Exchange.